Isolated Poliovirus Capsid Protein VP1 Induces a Neutralizing Response in Rats

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1982 Dec 1

PMID 6296837

Citations 25

Authors

M Chow

D Baltimore

Affiliations

Soon will be listed here.

Abstract

Antibodies were raised in rats against the poliovirus type 1 capsid proteins, VP1, VP2, and VP3. Antibodies directed against VP1 from type 1 poliovirus (Mahoney) neutralized type 1 but not type 2 poliovirus. Antibodies raised against VP2 and VP3 failed to neutralize type 1 virus. Thus, VP1 appears to be a neutralizing antigen for poliovirus and in its denatured form presents to the immune system its neutralizing determinants.

Citing Articles

Cross-Reactive Antibody Responses against Nonpoliovirus Enteroviruses.

Rosenfeld A, Shen E, Melendez M, Mishra N, Lipkin W, Racaniello V mBio. 2022; 13(1):e0366021.

PMID: 35038922 PMC: 8764532. DOI: 10.1128/mbio.03660-21.

The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus.

Wu C, Yu S, Chen Y, Chen Y, Hsiao P, Chow Y PLoS One. 2019; 14(1):e0210553.

PMID: 30650163 PMC: 6334917. DOI: 10.1371/journal.pone.0210553.

Development of Thermostable Lyophilized Sabin Inactivated Poliovirus Vaccine.

Shin W, Hara D, Gbormittah F, Chang H, Chang B, Jung J mBio. 2018; 9(6).

PMID: 30482835 PMC: 6282204. DOI: 10.1128/mBio.02287-18.

Defining the Enterovirus Diversity Landscape of a Fecal Sample: A Methodological Challenge?.

Faleye T, Adewumi M, Adeniji J Viruses. 2016; 8(1).

PMID: 26771630 PMC: 4728578. DOI: 10.3390/v8010018.

Cholesterol removal by methyl-beta-cyclodextrin inhibits poliovirus entry.

Danthi P, Chow M J Virol. 2003; 78(1):33-41.

PMID: 14671085 PMC: 303393. DOI: 10.1128/jvi.78.1.33-41.2004.

References

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Roizman B, Mayer M, Rapp H . Immunochemical studies of poliovirus. III. Further studies on the immunologic and physical properties of poliovirus particles produced in tissue culture. J Immunol. 1958; 81(5):419-25. View

Icenogle J, Gilbert S, Grieves J, Anderegg J, Rueckert R . A neutralizing monoclonal antibody against poliovirus and its reaction with related antigens. Virology. 1981; 115(1):211-5. DOI: 10.1016/0042-6822(81)90103-3. View

Hummeler K, ANDERSON T, BROWN R . Identification of poliovirus particles of different antigenicity by specific agglutination as seen in the electron microscope. Virology. 1962; 16:84-90. DOI: 10.1016/0042-6822(62)90205-2. View

Hummeler K, Hamparian V . Studies on the complement fixing antigens of poliomyelitis. I. Demonstration of type and group specific antigens in native and heated viral preparations. J Immunol. 1958; 81(6):499-505. View

Lund G, Ziola B, Salmi A, Scraba D . Structure of the Mengo virion. V. Distribution of the capsid polypeptides with respect to the surface of the virus particle. Virology. 1977; 78(1):35-44. DOI: 10.1016/0042-6822(77)90076-9. View

Hummeler K, TUMILOWICZ J . Studies on the complement-fixing antigens of poliomylitis. II. Preparation of type-specific anti-N and anti-H indicator sera. J Immunol. 1960; 84:630-4. View

LE BOUVIER G . The D to C change in poliovirus particles. Br J Exp Pathol. 1959; 40:605-20. PMC: 2082323. View

Wetz K, HABERMEHL K . Topographical studies on poliovirus capsid proteins by chemical modification and cross-linking with bifunctional reagents. J Gen Virol. 1979; 44(2):525-34. DOI: 10.1099/0022-1317-44-2-525. View

10.

Breindl M . VP 4, the D-reactive part of poliovirus. Virology. 1971; 46(3):962-4. DOI: 10.1016/0042-6822(71)90097-3. View

11.

Joklik W, Darnell Jr J . The adsorption and early fate of purified poliovirus in HeLa cells. Virology. 1961; 13:439-47. DOI: 10.1016/0042-6822(61)90275-6. View

12.

LONBERG-HOLM K, Butterworth B . Investigation of the structure of polio- and human rhinovirions through the use of selective chemical reactivity. Virology. 1976; 71(1):207-16. DOI: 10.1016/0042-6822(76)90106-9. View

13.

Kaaden O, Adam K, Strohmeier K . Induction of neutralizing antibodies and immunity in vaccinated guinea pigs by cyanogen bromide-peptides of VP3 of foot-and-mouth disease virus. J Gen Virol. 1977; 34(2):397-400. DOI: 10.1099/0022-1317-34-2-397. View

14.

Meloen R, Rowlands D, Brown F . Comparison of the antibodies elicited by the individual structural polypeptides of foot-and mouth disease and polio viruses. J Gen Virol. 1979; 45(3):761-3. DOI: 10.1099/0022-1317-45-3-761. View

15.

Blondel B, Crainic R, HORODNICEANU F . [Structural polypeptide VP1 in poliovirus type 1 induced by neutralizing antibodies]. C R Seances Acad Sci III. 1982; 294(2):91-4. View

16.

Bittle J, Houghten R, Alexander H, Shinnick T, Sutcliffe J, Lerner R . Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature. 1982; 298(5869):30-3. DOI: 10.1038/298030a0. View

17.

Bachrach H, Moore D, McKERCHER P, Polatnick J . Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. J Immunol. 1975; 115(6):1636-41. View

18.

. Picornaviridae: second report. Intervirology. 1978; 10(3):165-80. DOI: 10.1159/000148981. View

19.

Baxt B, Bachrach H . The adsorption and degradation of foot-and-mouth disease virus by isolated BHK-21 cell plasma membranes. Virology. 1982; 116(2):391-405. DOI: 10.1016/0042-6822(82)90134-9. View

20.

Ghendon Y, Yakobson E . Antigenic specificity of poliovirus-related particles. J Virol. 1971; 8(4):589-90. PMC: 376232. DOI: 10.1128/JVI.8.4.589-590.1971. View